<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Yu J</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Higher homocysteine (Hcy) level has been suggested to be associated with major psychiatric disorders (MPDs), such as schizophrenia (SCZ), bipolar disorder (BD), and major depressive disorder (MDD). We investigated the causal relationships between plasma Hcy level and MPDs risks using the Mendelian randomization (MR) method.&lt;h4>Methods&lt;/h4>We selected 18 loci associated with plasma Hcy level from a large-scale genome-wide association study (GWAS) as genetic instruments. Genetic associations with SCZ, MDD, BD and BD subtypes (BD-I and BD-II) were extracted from several GWAS datasets from the Psychiatric Genomics Consortium. We used the Generalized Summary-data-based Mendelian Randomization (GSMR) method to estimate the associations of genetically predicted plasma Hcy level</pubmed_abstract><journal>Frontiers in psychiatry</journal><pagination>841429</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8977462</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The Effects of Plasma Homocysteine Level on the Risk of Three Major Psychiatric Disorders: A Mendelian Randomization Study.</pubmed_title><pmcid>PMC8977462</pmcid><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Xue R</pubmed_authors><pubmed_authors>Wang Q</pubmed_authors><pubmed_authors>Yu J</pubmed_authors><pubmed_authors>Yu H</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Effects of Plasma Homocysteine Level on the Risk of Three Major Psychiatric Disorders: A Mendelian Randomization Study.</name><description>&lt;h4>Background&lt;/h4>Higher homocysteine (Hcy) level has been suggested to be associated with major psychiatric disorders (MPDs), such as schizophrenia (SCZ), bipolar disorder (BD), and major depressive disorder (MDD). We investigated the causal relationships between plasma Hcy level and MPDs risks using the Mendelian randomization (MR) method.&lt;h4>Methods&lt;/h4>We selected 18 loci associated with plasma Hcy level from a large-scale genome-wide association study (GWAS) as genetic instruments. Genetic associations with SCZ, MDD, BD and BD subtypes (BD-I and BD-II) were extracted from several GWAS datasets from the Psychiatric Genomics Consortium. We used the Generalized Summary-data-based Mendelian Randomization (GSMR) method to estimate the associations of genetically predicted plasma Hcy level</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2026-05-30T15:03:23.087Z</modification><creation>2025-04-04T23:03:11.325Z</creation></dates><accession>S-EPMC8977462</accession><cross_references><pubmed>35386526</pubmed><doi>10.3389/fpsyt.2022.841429</doi></cross_references></HashMap>